CLINICAL TRIALS PROFILE FOR ELESTAT
✉ Email this page to a colleague
All Clinical Trials for ELESTAT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00534794 ↗ | Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis | Completed | Merck Sharp & Dohme Corp. | Phase 4 | 2007-10-01 | The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis. |
NCT01569191 ↗ | Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis | Completed | University of Worcester | Phase 4 | 2012-03-01 | Seasonal allergic conjunctivitis (SAC) is an irritating eye condition that affects many people, caused by hypersensitivity to normally harmless substances such as pollen, and often accompanies seasonal hay fever. Treatments that can be used before initiating medical therapy include artificial tear supplements (ATS) and cold compresses (CC). However, there is no evidence in the scientific literature that demonstrates their efficacy compared to no treatment or their combined effect with anti-allergic medication. Therefore the investigators aim to examine the efficacy of ATS and CC alone, in comparison to anti-allergic medication, and CC in combination with anti-allergic medication. In addition, the investigators also aim to determine the time course of ocular allergic reactions. At the end of the study the investigators will be able to see whether or not ATS and CC are effective in treating SAC. |
NCT01569191 ↗ | Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis | Completed | Aston University | Phase 4 | 2012-03-01 | Seasonal allergic conjunctivitis (SAC) is an irritating eye condition that affects many people, caused by hypersensitivity to normally harmless substances such as pollen, and often accompanies seasonal hay fever. Treatments that can be used before initiating medical therapy include artificial tear supplements (ATS) and cold compresses (CC). However, there is no evidence in the scientific literature that demonstrates their efficacy compared to no treatment or their combined effect with anti-allergic medication. Therefore the investigators aim to examine the efficacy of ATS and CC alone, in comparison to anti-allergic medication, and CC in combination with anti-allergic medication. In addition, the investigators also aim to determine the time course of ocular allergic reactions. At the end of the study the investigators will be able to see whether or not ATS and CC are effective in treating SAC. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ELESTAT
Condition Name
Clinical Trial Locations for ELESTAT
Trials by Country
Clinical Trial Progress for ELESTAT
Clinical Trial Phase
Clinical Trial Sponsors for ELESTAT
Sponsor Name